Michael Spartalis

Dr. Michael Spartalis

National and Kapodistrian University of Athens, Athens, Attikí, Greece
orcid

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 August 2017 in Annals of Translational Medicine
Verified
Journal Article
Closed access
PDF file
DMDemetrios Moris
Demetrios Moris
Michael SpartalisMichael Spartalis
Michael Spartalis
ESEleftherios Spartalis
Eleftherios Spartalis
GKGeorgia-Sofia Karachaliou
Georgia-Sofia Karachaliou
GKGeorgios I. Karaolanis
Georgios I. Karaolanis
STStamatios Theocharis
Stamatios Theocharis
Acute and chronic excessive intracellular increase of reactive oxygen species (ROS) is involved in the development and progression of cardiovascular diseases. ROS are by-products of various oxidative physiological and biochemical processes. Sources of ROS are mitochondrial respiration, NADH/NADPH oxidase, xanthine oxidoreductase or the uncoupling of nitric oxide synthase (NOS) in vascular cells. ROS mediate various signaling pathways that underlie cardiovascular pathophysiology. The delicate equilibrium between free-radical generation and antioxidant defense is altered in favor of the former, thus leading to redox imbalance, oxidative stress, and increased cellular injury. An understanding of the pathophysiological mechanisms mediated by oxidative stress is crucial to the prevention and treatment of cardiovascular diseases.

1 August 2017 in Annals of Translational Medicine
Verified
Journal Article
Closed access
PDF file
DMDemetrios Moris
Demetrios Moris
Michael SpartalisMichael Spartalis
Michael Spartalis
ETEleni Tzatzaki
Eleni Tzatzaki
ESEleftherios Spartalis
Eleftherios Spartalis
GKGeorgia-Sofia Karachaliou
Georgia-Sofia Karachaliou
STStamatios Theocharis
Stamatios Theocharis
Reactive oxygen species (ROS) are subcellular messengers in gene regulatory and signal transduction pathways. In pathological situations, ROS accumulate due to excessive production or insufficient degradation, leading to oxidative stress (OS). OS causes oxidation of DNA, membranes, cellular lipids, and proteins, impairing their normal function and leading ultimately to cell death. OS in the heart is increased in response to ischemia/reperfusion, hypertrophy, and heart failure. The concentration of ROS is determined by their rates of production and clearance by antioxidants. Increases in OS in heart failure are primarily a result of the functional uncoupling of the respiratory chain due to inactivation of complex I. However, increased ROS in the failing myocardium may also be caused by impaired antioxidant capacity, such as decreased activity of Cu/Zn superoxide dismutase (SOD) and catalase (CAT) or stimulation of enzymatic sources, including, cyclooxygenase, xanthine oxidase (XO), nitric oxide synthase, and nonphagocytic NAD(P)H oxidases (Noxs). Mitochondria are the main source of ROS during heart failure and aging. Increased production of ROS in the failing heart leads to mitochondrial permeability transition, which results in matrix swelling, outer membrane rupture, a release of apoptotic signaling molecules, and irreversible injury to the mitochondria. Alterations of “redox homeostasis” leads to major cellular consequences, and cellular survival requires an optimal regulation of the redox balance.

1 June 2018 in Maturitas
Verified
Journal Article
Closed access
DPDimitra I. Pavlou
Dimitra I. Pavlou
SPStavroula A. Paschou
Stavroula A. Paschou
PAPanagiotis Anagnostis
Panagiotis Anagnostis
Michael SpartalisMichael Spartalis
Michael Spartalis
ESEleftherios Spartalis
Eleftherios Spartalis
GSGerasimos Siasos
Gerasimos Siasos

8 June 2019 in Anticancer Research
Verified
Journal Article
Closed access
PDF file
ESEleftherios Spartalis
Eleftherios Spartalis
IDIoannis Drikos
Ioannis Drikos
AIArgyrios Ioannidis
Argyrios Ioannidis
DCDimosthenis Chrysikos
Dimosthenis Chrysikos
DADimitrios I. Athanasiadis
Dimitrios I. Athanasiadis
DADimitrios Avgerinos
Dimitrios Avgerinos
Background/Aim: Adrenal glands are one of the most common sites of cancer metastasis. The treatment options include either surgery or chemotherapy and/or radiotherapy while certain diagnosis is made via percutaneous biopsy or fine needle aspiration (FNA), guided by CT scan. This review aimed to present the current practice regarding the diagnosis and treatment of adrenal cancer metastasis. Materials and Methods: A PRISMA-compliant systematic search of the PubMed, Cochrane, EMBASE, AMED, CINAHL, WoS, BIOSIS, LILACS, ASSIA, SCEH, SCIRUS databases, and JIT medical feed sources was performed through November 5th, 2018. Results: A total of 87 original studies including 660 patients with adrenal metastasis were analyzed. Most preferred treatment was excision of the gland in 76.58% of the cases, while most of adrenal metastases were found at autopsy (43.88%) followed by computed tomography guided biopsy (33.09%). Conclusion: Adrenalectomy following metastatic disease to the adrenals should be performed when the lesion is isolated in the gland and the site of primary cancer has or can be resected.

25 September 2018 in Journal of Robotic Surgery
Verified
Journal Article
Closed access
PDF file
Ilias P. DoulamisIlias P. Doulamis
Ilias P. Doulamis
ESEleftherios Spartalis
Eleftherios Spartalis
NMNikolaos Machairas
Nikolaos Machairas
DSDimitrios Schizas
Dimitrios Schizas
DPDimitrios Patsouras
Dimitrios Patsouras
NNNikolaos I. Nikiteas
Nikolaos I. Nikiteas

1 March 2020 in Current Medicinal Chemistry
Verified
Journal Article
Closed access
PDF file
EVANGELOS OIKONOMOUEVANGELOS OIKONOMOU
EVANGELOS OIKONOMOU
GSGerasimos Siasos
Gerasimos Siasos
VTVasiliki Tsigkou
Vasiliki Tsigkou
EBEvanthia Bletsa
Evanthia Bletsa
MPMaria-Evi Panoilia
Maria-Evi Panoilia
DTDimitris Tousoulis
Dimitris Tousoulis
Coronary artery disease is the leading cause of morbidity and mortality worldwide. The most common pathophysiologic substrate is atherosclerosis which is an inflammatory procedure that starts at childhood and develops throughout life. Endothelial dysfunction is associated with the initiation and progression of atherosclerosis and is characterized by the impaired production of nitric oxide. In general, endothelial dysfunction is linked to poor cardiovascular prognosis and different methods, both invasive and non-invasive, have been developed for its evaluation. Ultrasound evaluation of flow mediated dilatation of the branchial artery is the most commonly used method to assessed endothelial function while intracoronary administration of vasoactive agents may be also be used to test directly endothelial properties of the coronary vasculature. Endothelial dysfunction has also been the subject of therapeutic interventions. This review article summarizes the knowledge about evaluation of endothelial function in acute coronary syndromes and stable coronary artery disease and demonstrates the current therapeutic approaches against endothelial dysfunction.